Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease : The Bypass Angioplasty Revascularization Investigation (BARI)
In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain. From the Bypass Angioplasty Revascularization Invest...
Saved in:
Published in | Circulation (New York, N.Y.) Vol. 100; no. 9; pp. 910 - 917 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
31.08.1999
American Heart Association, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain.
From the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (P<0. 001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG.
Overall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined. |
---|---|
AbstractList | Background
—In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain.
Methods and Results
—From the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (
P
<0.001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG.
Conclusions
—Overall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined. In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain. From the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (P<0. 001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG. Overall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined. BACKGROUNDIn PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain.METHODS AND RESULTSFrom the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (P<0. 001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG.CONCLUSIONSOverall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined. BACKGROUND: In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain. METHODS AND RESULTS: From the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (P<0. 001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG. CONCLUSIONS: Overall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined. |
Author | KIP, K. E DETRE, K. M BOURASSA, M. G SHARAF, B. L DIMAS, A. P JACOBS, A. K SOPKO, G SCHWARTZ, L ALDERMAN, E. L KELLETT, M. A FEIT, F WEISS, M. B JONES, R. H WEINER, B. H |
Author_xml | – sequence: 1 givenname: K. E surname: KIP fullname: KIP, K. E organization: Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pa, United States – sequence: 2 givenname: M. G surname: BOURASSA fullname: BOURASSA, M. G organization: Montreal Heart Institute, Montreal, Canada – sequence: 3 givenname: A. P surname: DIMAS fullname: DIMAS, A. P organization: Cleveland, Clinic Foundation, Cleveland, Ohio, United States – sequence: 4 givenname: R. H surname: JONES fullname: JONES, R. H organization: Duke University Medical Center, Durham, NC, United States – sequence: 5 givenname: G surname: SOPKO fullname: SOPKO, G organization: National Heart, Lung, and Blood Institute, Bethesda, Md, United States – sequence: 6 givenname: K. M surname: DETRE fullname: DETRE, K. M organization: Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pa, United States – sequence: 7 givenname: A. K surname: JACOBS fullname: JACOBS, A. K organization: Boston Medical Center, Boston, Mass, Canada – sequence: 8 givenname: L surname: SCHWARTZ fullname: SCHWARTZ, L organization: Toronto Hospital, Toronto, Canada – sequence: 9 givenname: F surname: FEIT fullname: FEIT, F organization: New York University Medical Center, New York, NY, United States – sequence: 10 givenname: E. L surname: ALDERMAN fullname: ALDERMAN, E. L organization: Stanford University Medical Center, Palo Alto, Calif, United States – sequence: 11 givenname: B. H surname: WEINER fullname: WEINER, B. H organization: University of Massachusetts Medical Center, Worcester, Mass, United States – sequence: 12 givenname: M. B surname: WEISS fullname: WEISS, M. B organization: New York, Medical College, Valhalla, NY, United States – sequence: 13 givenname: M. A surname: KELLETT fullname: KELLETT, M. A organization: Maine Medical Center, Portland, Me, United States – sequence: 14 givenname: B. L surname: SHARAF fullname: SHARAF, B. L organization: Rhode Island Hospital, Providence, RI, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1916188$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10468520$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkU9vEzEQxS1URNPCnROyEEJw2GVs719uaVRgpUqgKJwtxzubunK8i-0tCl-lXxaXRAJxst74N29G8y7ImRsdEvKSQc5YxT4Ay1fdOmcAeZu3DJ6QBSt5kRWlaM_IAgDarBacn5OLEO6SrERdPiPnDIqqKTksyEPnBjuj00jHgU4es2-b1ZKG6FXE3YEq11PjTDTK0j8_HsNsY6rRSUWDLgb608Rbuk9Vc48hoKW9CagC0o90c4v06jCpEOjS7cw4WRXiga7xXgU9W-XNr-QyOtq51BvN7qjeXS3X3fvn5OmgbMAXp_eSfP90vVl9yW6-fu5Wy5tMi6KMWdVvC2w5V7rvFa-4VhxhgJIL0XDGFVRDiQPTqLko-4EDL6Bui76ALbCGVeKSvD36Tn78Mac15N4EjdYqh-McZP14ON6IBL7-D7wbZ-_SbjINqgvGG5YgOELajyF4HOTkzV75g2QgH1OTwGRKLUmQrUyppZZXJ995u8f-n4ZjTAl4cwLS2ZQdvHLahL9cm2ybRvwGzX-hpQ |
CODEN | CIRCAZ |
Cites_doi | 10.1016/0002-8703(88)90511-X 10.1161/circ.71.4.3156011 10.1056/NEJM199607253350401 10.1016/S0002-9149(99)80389-0 10.1016/S0003-4975(97)00451-7 10.1016/0735-1097(88)90278-1 10.1161/circ.78.2.2969312 10.1016/0002-9149(87)90287-6 10.1016/0002-8703(90)90154-P 10.1161/circ.75.4.3103950 10.1016/0002-9149(92)91271-5 10.1016/S0002-9149(97)89173-4 10.1016/S0735-1097(85)80298-9 10.1111/j.2517-6161.1972.tb00899.x 10.1016/0735-1097(90)90342-M 10.1016/0735-1097(93)90532-6 10.1016/S0735-1097(84)80263-6 10.1016/S0002-9149(99)80390-7 10.1161/circ.77.3.2963707 10.1161/circ.96.7.2162 10.1016/0002-8703(94)90377-8 10.1016/0002-8703(92)90687-Q |
ContentType | Journal Article |
Copyright | 1999 INIST-CNRS Copyright American Heart Association, Inc. Aug 31, 1999 |
Copyright_xml | – notice: 1999 INIST-CNRS – notice: Copyright American Heart Association, Inc. Aug 31, 1999 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION K9. NAPCQ U9A 7X8 |
DOI | 10.1161/01.CIR.100.9.910 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Career and Technical Education (Alumni Edition) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1524-4539 |
EndPage | 917 |
ExternalDocumentID | 44541776 10_1161_01_CIR_100_9_910 10468520 1916188 |
Genre | Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 08R 0R~ 0ZK 18M 1CY 1J1 29B 2FS 2WC 354 40H 41~ 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ 8W4 AAAXR AAEJM AAGIX AAHPQ AAJCS AAMOA AAMTA AAPBV AAQKA AARTV AASOK AASXQ AAWTL AAXQO AAYOK ABASU ABBUW ABDIG ABFLS ABOCM ABPMR ABPTK ABQRW ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACOAL ACRKK ACRZS ACWDW ACWRI ACXNZ ADBBV ADCYY ADFPA ADGIM ADNKB AE3 AE6 AEBDS AENEX AFCHL AFDTB AFFNX AFUWQ AGINI AHMBA AHRYX AHVBC AIJEX AJIOK AJJEV AJNYG AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR ASPBG AVWKF AWKKM AYCSE AZFZN BAWUL BOYCO BQLVK BS7 BYPQX C1A C45 CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EJD EX3 F2K F2L F2M F2N F5P FEDTE FL- FW0 GQDEL GX1 H0~ H13 HVGLF HZ~ H~9 IKREB IKYAY IN~ IPNFZ IQODW J5H JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B M18 MVM N4W N9A NEJ N~7 N~B N~M O9- OAG OAH OBH OCB OCUKA ODA ODMTH OGEVE OHH OHT OHYEH OJAPA OK1 OL1 OLB OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQEST PQQKQ R58 RAH RHF RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WHG WOQ WOW X3V X3W X7M XXN XYM YFH YOC YQJ YSK YXB YYM YYP YZZ ZA5 ZFV ZGI ZXP ZY1 ZZMQN ~H1 AAAAV AAIQE AAUEB ABJNI ACILI ADGGA ADHPY AEETU AFEXH AHOMT AHQNM AINUH AJNWD AJZMW AMNEI CGR CUY CVF ECM EIF FCALG NPM AAYXX CITATION K9. NAPCQ U9A 7X8 |
ID | FETCH-LOGICAL-c345t-6db4e922acdda262ca2e0f052338212a06f5ef1cec235df20240794d40b018163 |
ISSN | 0009-7322 |
IngestDate | Fri Oct 25 23:11:29 EDT 2024 Thu Oct 10 19:14:21 EDT 2024 Fri Aug 23 01:07:26 EDT 2024 Wed Oct 16 00:50:48 EDT 2024 Fri Nov 25 06:01:32 EST 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Human Multiple Prognosis Coronary artery Instrumentation therapy Stenosis Cardiovascular disease Instrumental dilatation Coronary heart disease Artery Arterial disease Vascular disease Treatment Follow up study |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c345t-6db4e922acdda262ca2e0f052338212a06f5ef1cec235df20240794d40b018163 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 10468520 |
PQID | 212741281 |
PQPubID | 24119 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_70006283 proquest_journals_212741281 crossref_primary_10_1161_01_CIR_100_9_910 pubmed_primary_10468520 pascalfrancis_primary_1916188 |
PublicationCentury | 1900 |
PublicationDate | 1999-08-31 |
PublicationDateYYYYMMDD | 1999-08-31 |
PublicationDate_xml | – month: 08 year: 1999 text: 1999-08-31 day: 31 |
PublicationDecade | 1990 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States – name: Baltimore |
PublicationTitle | Circulation (New York, N.Y.) |
PublicationTitleAlternate | Circulation |
PublicationYear | 1999 |
Publisher | Lippincott Williams & Wilkins American Heart Association, Inc |
Publisher_xml | – name: Lippincott Williams & Wilkins – name: American Heart Association, Inc |
References | (e_1_3_1_17_2) 1992; 3 e_1_3_1_21_2 (e_1_3_1_22_2) 1972; 34 e_1_3_1_23_2 e_1_3_1_8_2 e_1_3_1_13_2 (e_1_3_1_24_2) 1995; 75 e_1_3_1_7_2 e_1_3_1_12_2 e_1_3_1_11_2 e_1_3_1_9_2 e_1_3_1_10_2 e_1_3_1_20_2 e_1_3_1_4_2 e_1_3_1_3_2 e_1_3_1_16_2 e_1_3_1_6_2 e_1_3_1_15_2 e_1_3_1_5_2 e_1_3_1_14_2 e_1_3_1_2_2 e_1_3_1_19_2 e_1_3_1_1_2 e_1_3_1_18_2 |
References_xml | – ident: e_1_3_1_5_2 doi: 10.1016/0002-8703(88)90511-X – ident: e_1_3_1_1_2 doi: 10.1161/circ.71.4.3156011 – ident: e_1_3_1_15_2 doi: 10.1056/NEJM199607253350401 – ident: e_1_3_1_16_2 doi: 10.1016/S0002-9149(99)80389-0 – ident: e_1_3_1_12_2 doi: 10.1016/S0003-4975(97)00451-7 – ident: e_1_3_1_6_2 doi: 10.1016/0735-1097(88)90278-1 – ident: e_1_3_1_18_2 doi: 10.1161/circ.78.2.2969312 – ident: e_1_3_1_3_2 doi: 10.1016/0002-9149(87)90287-6 – ident: e_1_3_1_8_2 doi: 10.1016/0002-8703(90)90154-P – ident: e_1_3_1_19_2 doi: 10.1161/circ.75.4.3103950 – ident: e_1_3_1_14_2 – ident: e_1_3_1_13_2 doi: 10.1016/0002-9149(92)91271-5 – ident: e_1_3_1_20_2 doi: 10.1016/S0002-9149(97)89173-4 – ident: e_1_3_1_2_2 doi: 10.1016/S0735-1097(85)80298-9 – volume: 34 start-page: 187 year: 1972 ident: e_1_3_1_22_2 publication-title: J R Stat Soc (B) doi: 10.1111/j.2517-6161.1972.tb00899.x – ident: e_1_3_1_7_2 doi: 10.1016/0735-1097(90)90342-M – ident: e_1_3_1_10_2 doi: 10.1016/0735-1097(93)90532-6 – ident: e_1_3_1_23_2 doi: 10.1016/S0735-1097(84)80263-6 – volume: 75 start-page: 9C year: 1995 ident: e_1_3_1_24_2 publication-title: Am J Cardiol doi: 10.1016/S0002-9149(99)80390-7 – ident: e_1_3_1_4_2 doi: 10.1161/circ.77.3.2963707 – ident: e_1_3_1_21_2 doi: 10.1161/circ.96.7.2162 – ident: e_1_3_1_11_2 doi: 10.1016/0002-8703(94)90377-8 – ident: e_1_3_1_9_2 doi: 10.1016/0002-8703(92)90687-Q – volume: 3 start-page: 1189 year: 1992 ident: e_1_3_1_17_2 publication-title: Coron Artery Dis |
SSID | ssj0006375 |
Score | 1.7518996 |
Snippet | In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion... Background —In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial... BACKGROUND: In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial... BACKGROUNDIn PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 910 |
SubjectTerms | Aged Angioplasty, Balloon, Coronary Biological and medical sciences Cardiology. Vascular system Confounding Factors (Epidemiology) Coronary Disease - pathology Coronary Disease - therapy Coronary heart disease Disease-Free Survival Female Follow-Up Studies Heart Humans Male Medical sciences Middle Aged Multivariate Analysis Severity of Illness Index Treatment Outcome |
Title | Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease : The Bypass Angioplasty Revascularization Investigation (BARI) |
URI | https://www.ncbi.nlm.nih.gov/pubmed/10468520 https://www.proquest.com/docview/212741281 https://search.proquest.com/docview/70006283 |
Volume | 100 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahgzEYY2t3ybpuehiDEezZsizbjyF0a9p1lC6Fwh6MLEs00DkhcTq6f7N_uqOLHbeksO7FJFasyD6fj879IPQ-znhchoH0QNYuPEoT7hWpJF6UCpWWqVKM6Wzk42_s4Iwensfnvd6fTtTSqi588XtjXsn_UBXOAV11luw9KNtOCifgM9AXjkBhOP4TjcdNhxETybaQ3slkNBy4grPXLtR3WmujuBk5lcvVpekJcGLLqero1_piYLJwr3QVcc0D1x6bpoLBdCFcl69NzXs6xoSj6dwm-1zBf-z7ra4PNwNCOnfJQWZBX9rRQ2DKhW2KfAlsa3DUjnwXF7_g58bG_VWCzmArAFgrha1skDbsveG8mZdENgfZl47ZEurR2BYzarlxEHRgl3V4a-biX6X7lmzeAVhoshr80fhUh4D4md9e2C22fWsTbEMTjVLEwjwIc5hBl3TOszzTSXwPCPAyEwkwPmo3exYlcdOsT99e4wln4afba7gh-Tye8yW8hMp2T7lbvTFizuQpeuL0Ezy0YHuGerLaRjvDitezn9f4AzYRw8YVs40eHrvAjB30o4UinincQBE3UMQAReygiM2IhSKeVriBItZQxB0oYgfF5-js8_5kdOC5vh2eiGhce6wsqMwI4aIsOWFEcCIDpf0PUQqSEg-YiqUKhRQkiktFdJk92BZKqo3yKSgIL9BWNavkK4R1C6UwETRQMKcgIU8TwrVJQfGIUZ710cfmmeZzW54lv4uCfbR346GvL8h014i0j3YbIuTuJV_mugEC1d7mPnrXjgIH1m41XsnZapkngUlEjvropaVcZyWUpTEJXt9jlbvo0fr9eYO26sVK7oHcWxdvDfL-Ak7UpO8 |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+Pre-PTCA+Strategy+and+Initial+PTCA+Result+in+Patients+With+Multivessel+Disease&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Kip%2C+Kevin+E.&rft.au=Bourassa%2C+Martial+G.&rft.au=Jacobs%2C+Alice+K.&rft.au=Schwartz%2C+Leonard&rft.date=1999-08-31&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=100&rft.issue=9&rft.spage=910&rft.epage=917&rft_id=info:doi/10.1161%2F01.CIR.100.9.910&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_01_CIR_100_9_910 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon |